TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -12,035.15%-1.75B | ---- | -173.99%-1.29B | ---- | -99.39%14.66M | ---- | -66.62%1.74B | ---- | -24.85%2.42B |
Profit adjustment | ||||||||||
Investment loss (gain) | ---- | -47.00%-189.79M | ---- | 47.70%-131.52M | ---- | 31.22%-129.1M | ---- | 68.27%-251.48M | ---- | 46.86%-187.7M |
Impairment and provisions: | ---- | 158.69%388.41M | ---- | 54.74%1.98B | ---- | 33.80%150.14M | ---- | -6.06%1.28B | ---- | -37.36%112.22M |
-Other impairments and provisions | ---- | -5.00%57.78M | ---- | -72.69%123.83M | ---- | -24.26%60.83M | ---- | 27.67%453.46M | ---- | -37.33%80.31M |
Revaluation surplus: | ---- | 37.61%-210.06M | ---- | -100.11%-1.17B | ---- | -9.02%-336.7M | ---- | 15.72%-583.06M | ---- | -28.28%-308.85M |
Asset sale loss (gain): | ---- | -56.14%-1.07B | ---- | 8.84%-1.26B | ---- | 46.82%-686M | ---- | -50.69%-1.38B | ---- | -181.34%-1.29B |
-Loss (gain) on sale of property, machinery and equipment | ---- | -56.14%-1.07B | ---- | 8.84%-1.26B | ---- | 46.82%-686M | ---- | -50.69%-1.38B | ---- | -181.34%-1.29B |
Depreciation and amortization: | ---- | 1.32%2.64B | ---- | 7.02%5.25B | ---- | 9.15%2.6B | ---- | 5.87%4.9B | ---- | 2.30%2.38B |
-Amortization of intangible assets | ---- | -10.57%274.19M | ---- | 3.64%559.74M | ---- | 21.66%306.59M | ---- | -11.86%540.11M | ---- | -14.19%252.01M |
-Other depreciation and amortization | ---- | -1.33%184.05M | ---- | 25.41%410.98M | ---- | 31.78%186.54M | ---- | 13.08%327.72M | ---- | 38.11%141.55M |
Financial expense | ---- | 22.57%1.63B | ---- | -13.73%2.39B | ---- | -9.48%1.33B | ---- | 9.47%2.77B | ---- | 7.70%1.47B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 13.39%6.09B | ---- | 73.86%11.73B | ---- | -30.33%5.37B | ---- | 235.73%6.75B | ---- | 59.43%7.7B |
Accounts receivable (increase)decrease | ---- | -40.89%-4.74B | ---- | 245.42%1.52B | ---- | -34.48%-3.36B | ---- | -144.65%-1.04B | ---- | -1,754.94%-2.5B |
Accounts payable increase (decrease) | ---- | -984.52%-7.02B | ---- | -3,978.16%-12.55B | ---- | 89.30%-647.38M | ---- | 87.69%-307.82M | ---- | -148,113.20%-6.05B |
Special items of business | ---- | 179.02%67.27M | ---- | 658.00%665.64M | ---- | -2,595.73%-85.12M | ---- | -83.89%87.82M | ---- | 98.13%-3.16M |
Adjustment items of business operations | -205.12%-9.46B | -198.46%-4.24B | -450.90%-4.92B | -53.34%6.48B | -31.30%9B | 14.61%4.3B | 590.07%1.4B | 5.22%13.88B | 58.95%13.09B | -65.05%3.75B |
Net cash from operations | -205.12%-9.46B | -198.86%-4.17B | -450.90%-4.92B | -48.87%7.14B | -31.30%9B | 12.44%4.22B | 590.07%1.4B | 1.68%13.97B | 58.95%13.09B | -64.52%3.75B |
Cash flow from investment activities | ||||||||||
Dividend received - investment | -1.33%265.96M | 12.41%219.86M | 17.48%79.28M | -19.84%398.89M | -44.86%269.54M | -51.22%195.58M | 176.68%67.49M | 0.11%497.59M | 0.07%488.8M | -12.10%400.98M |
Sale of fixed assets | -19.84%638.33M | -22.87%636.1M | -65.86%217.42M | 100.61%2.65B | -35.08%796.31M | -23.83%824.76M | 227.36%636.78M | -25.38%1.32B | 30.16%1.23B | 15.41%1.08B |
Purchase of fixed assets | 42.05%-1.48B | 28.04%-1.24B | 48.71%-434.73M | 44.66%-3.28B | 10.36%-2.56B | 37.06%-1.73B | 10.71%-847.6M | -18.56%-5.93B | -26.55%-2.86B | -44.65%-2.74B |
Sale of subsidiaries | 1,533.53%49.01M | --49.01M | ---- | ---- | -73.93%3M | ---- | ---- | ---- | --11.51M | ---- |
Acquisition of subsidiaries | ---- | ---- | ---3.85M | -25.30%-173.6M | ---- | ---- | ---- | 34.59%-138.55M | ---1.81B | ---124.67M |
Recovery of cash from investments | -72.24%698M | -93.92%145.28M | 18,268.56%136M | 554.30%3.31B | 55.63%2.51B | 483.70%2.39B | -99.07%740.4K | -13.67%505.35M | 15,856.87%1.62B | 4,101.88%409.4M |
Cash on investment | -175.80%-3.12B | -111.12%-1.49B | -4,229.66%-891.33M | -59.91%-3.46B | 72.40%-1.13B | 75.43%-707.24M | 95.88%-20.59M | 23.84%-2.16B | -7,428.78%-4.1B | ---2.88B |
Other items in the investment business | -127.02%-437.84M | -115.99%-197.42M | -130.33%-345.74M | 328.08%1.88B | 102.55%1.62B | 12.37%1.23B | 233.01%1.14B | 31.53%-823.99M | -26.78%799.88M | 294.26%1.1B |
Net cash from investment operations | -324.89%-3.39B | -185.06%-1.88B | -227.26%-1.24B | 119.67%1.32B | 132.63%1.51B | 180.40%2.21B | 144.94%976.68M | -5.14%-6.73B | -2,191.42%-4.63B | -1,196.95%-2.75B |
Net cash before financing | -222.33%-12.85B | -194.11%-6.05B | -359.07%-6.16B | 17.04%8.47B | 24.06%10.51B | 543.07%6.43B | 220.75%2.38B | -1.34%7.23B | 0.10%8.47B | -90.35%1,000M |
Cash flow from financing activities | ||||||||||
New borrowing | 7.54%62.96B | 30.88%28.41B | 42.75%21.6B | 10.52%52.23B | 24.12%58.55B | -0.58%21.71B | 16.28%15.13B | 21.78%47.26B | 132.35%47.17B | 52.73%21.84B |
Refund | 16.11%-49.37B | -3.78%-29.22B | -2.64%-16.94B | -4.18%-71.2B | -17.28%-58.85B | 8.52%-28.16B | -1.17%-16.5B | 6.88%-68.34B | -8.53%-50.18B | 11.67%-30.78B |
Issuance of bonds | ---- | -63.27%6.79B | -30.00%3.5B | 68.70%29.72B | ---- | 65.18%18.5B | 0.00%5B | -28.03%17.62B | ---- | 109.27%11.2B |
Dividends paid - financing | 14.72%-3.76B | 6.82%-2.49B | 9.49%-1.18B | 20.50%-5.55B | 26.57%-4.41B | 20.09%-2.67B | -2.08%-1.3B | 8.64%-6.98B | -12.05%-6B | 9.81%-3.34B |
Absorb investment income | 387.29%600.98M | 382.20%600.98M | 9,736.01%600.98M | -84.11%162.34M | -72.47%123.33M | -70.66%124.63M | -91.85%6.11M | -53.53%1.02B | 121.13%447.95M | 897.92%424.81M |
Other items of the financing business | 1,508.91%358.53M | 100.71%64.04M | 134.73%10.15M | -203.22%-9.83B | 80.60%-25.45M | -327.34%-9.02B | 97.55%-29.22M | -342.16%-3.24B | -258.01%-131.19M | -4,195.86%-2.11B |
Net cash from financing operations | 334.30%10.8B | 755.73%4.17B | 229.43%7.6B | 64.76%-4.46B | 46.96%-4.61B | 117.60%487M | 434.09%2.31B | 10.87%-12.67B | 49.24%-8.69B | 85.28%-2.77B |
Effect of rate | 205.14%5.87M | 31.49%-6.94M | 86.21%-1.48M | 104.59%1.73M | -123.21%-5.58M | 39.78%-10.13M | -715.26%-10.77M | -55.58%-37.8M | -914.16%-2.5M | -919.88%-16.82M |
Net Cash | -134.84%-2.05B | -127.24%-1.88B | -69.35%1.44B | 173.66%4B | 2,787.32%5.9B | 491.37%6.92B | 276.11%4.69B | 21.03%-5.43B | 97.46%-219.46M | 79.06%-1.77B |
Begining period cash | 40.96%13.78B | 40.96%13.78B | 40.59%13.74B | -35.88%9.78B | -35.88%9.78B | -35.88%9.78B | -35.88%9.78B | -31.17%15.25B | -31.17%15.25B | -31.17%15.25B |
Cash at the end | -25.13%11.73B | -28.75%11.89B | 5.04%15.18B | 40.96%13.78B | 4.28%15.67B | 23.93%16.68B | 14.80%14.45B | -35.88%9.78B | 11.34%15.02B | -1.80%13.46B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.